⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

September 1, 2024Translational Cancer ResearchOpen Access

Development and validation of a nomogram to predict overall survival of gastroenteropancreatic neuroendocrine carcinoma: a SEER database analysis

Qishuang Chen Yiying Guo Zihan Wang Xiaoying Chen Chao Tian Jiabin Zheng Huangying Tan

View Full Paper

Ask AI

Bookmark

Share

Abstract

Gastroenteropancreatic neuroendocrine carcinoma (GEP-NEC) is a rare group of diseases with poor prognosis and the assessment of its prognosis is a significant challenge. This study aimed to develop and validate a prognostic nomogram to assess overall survival (OS) in patients with GEP-NEC.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Chen et al. (2024) studied this question.

synapsesocial.com/papers/68e5a0a6b6db64358753b220 https://doi.org/10.21037/tcr-23-2215

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Development and validation of nomograms to predict survival of neuroendocrine carcinoma in genitourinary system: A population-based retrospective study2024
2Gastroenteropancreatic Neuroendocrine Carcinoma (GEP-NEC): An Aggressive Disease Course and Limitations for Personalized OncologyOriginal Research · 2026
3Risk factors, prognostic factors, and nomograms for distant metastases in patients with gastroenteropancreatic neuroendocrine tumors: a population-based study2024 · 8 citations
4Treatment outcomes and survival in advanced gastroenteropancreatic neuroendocrine carcinomaCohort Study · 2026
5The survival outcome in proximal and distal gastric neuroendocrine carcinoma - A SEER-based competing risk nomogram2024